98 related articles for article (PubMed ID: 24793626)
1. [Detection of residual microscopic disease in melanoma: interest of the sentinel lymph node procedure?].
Mateus C; Thomas M; Robert C
Bull Cancer; 2014 Apr; 101(4):354-7. PubMed ID: 24793626
[TBL] [Abstract][Full Text] [Related]
2. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
McMasters KM; Edwards MJ; Ross MI; Reintgen DS; Martin RC; Urist MM; Noyes RD; Sussman JJ; Stromberg AJ; Scoggins CR
Ann Surg; 2010 Sep; 252(3):460-5; discussion 465-6. PubMed ID: 20739846
[TBL] [Abstract][Full Text] [Related]
3. [Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].
Orion C; Dinulescu M; Dalac-Rat S; Giacchero D; Jouary T; Lebbé C; Leccia MT; Maubec E; Meyer N; Mortier L; Dupuy A;
Ann Dermatol Venereol; 2020 Jan; 147(1):9-17. PubMed ID: 31761496
[TBL] [Abstract][Full Text] [Related]
4. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
[TBL] [Abstract][Full Text] [Related]
6. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
7. Lack of standards for the detection of melanoma in sentinel lymph nodes: a survey and recommendations.
Dekker J; Duncan LM
Arch Pathol Lab Med; 2013 Nov; 137(11):1603-9. PubMed ID: 24168497
[TBL] [Abstract][Full Text] [Related]
8. The current status of S-100B as a biomarker in melanoma.
Kruijff S; Hoekstra HJ
Eur J Surg Oncol; 2012 Apr; 38(4):281-5. PubMed ID: 22240030
[TBL] [Abstract][Full Text] [Related]
9. Pathologic examination of the sentinel lymph node.
Messina JL; Glass LF
J Fla Med Assoc; 1997 Mar; 84(3):153-6. PubMed ID: 9143165
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
11. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma].
Hauschild A; Lischner S; Christophers E
Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in melanoma: Facts and controversies.
Baldwin BT; Cherpelis BS; Sondak V; Fenske NA
Clin Dermatol; 2010; 28(3):319-23. PubMed ID: 20541686
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
14. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
[TBL] [Abstract][Full Text] [Related]
15. Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan.
Namikawa K; Yamazaki N; Nakai Y; Ihn H; Tomita Y; Uhara H; Takenouchi T; Kiyohara Y; Moroi Y; Yamamoto Y; Otsuka F; Kamiya H; Iizuka H; Hatta N; Kadono T
J Dermatol; 2012 Feb; 39(2):130-7. PubMed ID: 21950448
[TBL] [Abstract][Full Text] [Related]
16. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
17. Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
Bagaria SP; Ray PS; Joseph RW; Heckman MG; Rawal B; Gray RJ; Pockaj B; Wasif N
Cancer; 2013 May; 119(10):1860-7. PubMed ID: 23408288
[TBL] [Abstract][Full Text] [Related]
18. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
19. Randomized adjuvant therapy trials in melanoma: surgical and systemic.
Eggermont AM; Gore M
Semin Oncol; 2007 Dec; 34(6):509-15. PubMed ID: 18083374
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
